Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6T | 2.4T | 2.3T | 2.3T |
Cost of revenue | 1.8T | 1.7T | 1.7T | 1.7T |
Gross profit | 775.4B | 738.5B | 657.5B | 647.3B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 395.0B | 360.8B | 329.3B | 324.9B |
Operating income | 303.5B | 306.1B | 261.8B | 251.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 61.6B | 61.8B | 60.2B | 59.2B |
Other income expense | — | — | — | — |
Pretax income | 291.0B | 286.4B | 250.4B | 232.3B |
Tax provision | 66.7B | 68.4B | 59.4B | 57.9B |
Net income | 226.1B | 219.3B | 193.2B | 174.5B |
Basic EPS | — | 13.7 | 12.2 | 11.2 |
Diluted EPS | — | 13.7 | 12.2 | 11.2 |
Basic average shares | — | 13.5B | 13.5B | 13.5B |
Diluted average shares | — | 13.5B | 13.5B | 13.5B |
EBITDA | 352.6B | 348.2B | 310.5B | 291.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -32.0B | -33.9B | -27.6B | -23.1B |
Preferred stock dividends | 0 | 0 | 0 | 0 |